ADXS.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Stock prediction for ADXS.US - Ayala Pharmaceuticals Inc.

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

symbol	last	change	%chng	name	mcap	sector	wiki
ADXS				Ayala Pharmaceuticals Inc.	0.027B	Healthcare	wiki y

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	ADXS	0.56	0,-2.179,-2.079,-0.242,-2.179	0.59,0.55,1.05,0.72,0.87,0.88,0.78,0.69,0.60,0.67,0.62,0.64,0.60,0.55	0.53-0.91	29.73%	267,178,267	3.0	Nov 3-Jul 27	39.57%

stock prediction graph

prediction values

stock	low target	target	high target	to go	days	target date
ADXS	0.53	0.72	0.91	17.37%	267	Jul 27
ADXS	0.63	0.79	0.95	24.80%	177	Apr 28
ADXS	0.64	0.80	0.96	25.68%	167	Apr 18
ADXS	0.65	0.81	0.96	26.34%	157	Apr 8
ADXS	0.67	0.82	0.97	27.86%	147	Mar 29
ADXS	0.68	0.83	0.97	28.80%	137	Mar 19
ADXS	0.71	0.85	0.98	30.68%	127	Mar 9
ADXS	0.72	0.85	0.98	31.26%	117	Feb 28
ADXS	0.73	0.86	0.98	31.93%	107	Feb 18
ADXS	0.74	0.86	0.98	31.93%	97	Feb 8

``` ```